Patient-reported outcomes in FLT3-mutated AML patients treated with gilteritinib plus azacitidine VJHemOnc – Video Journal of Hematology & HemOnc 1:28 2 years ago 102 Далее Скачать
Dr. Levis on Gilteritinib in Relapsed/Refractory FLT3-Mutated AML OncLive 2:28 5 years ago 1 073 Далее Скачать
Novel potent and selective FLT3 inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 2:19 6 years ago 53 Далее Скачать
Top AML highlights from ASH 2024: menin inhibitors & gilteritinib versus midostaurin in induction VJHemOnc – Video Journal of Hematology & HemOnc 2:30 2 days ago 84 Далее Скачать
ADMIRAL: gilteritinib for R/R FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 3:01 3 years ago 505 Далее Скачать
Dr. Komrokji on the FDA Approval of Gilteritinib in FLT3+ AML OncLive 1:31 6 years ago 219 Далее Скачать
Gilteritinib Relapse Leads to Loss of FLT3-TKD Mutation in Patient With AML Targeted Oncology 1:12 4 years ago 220 Далее Скачать
Gilteritinib in R/R AML VJHemOnc – Video Journal of Hematology & HemOnc 6:24 4 years ago 190 Далее Скачать
Dr. Altman on Gilteritinib in Patients With Relapsed/Refractory AML OncLive 1:09 7 years ago 503 Далее Скачать
All about gilteritinib: When is gilteritinib used to treat FLT3-positive AML? #AML HealthTree University for Blood Cancers 2:47 1 year ago 692 Далее Скачать
Survival Improves With Gilteritinib in FLT3+ AML Targeted Oncology 1:43 5 years ago 652 Далее Скачать
ADMIRAL analysis: survival by mutation status in gilteritinib-treated FLT3+ R/R AML VJHemOnc – Video Journal of Hematology & HemOnc 3:21 5 years ago 155 Далее Скачать
Mechanisms of gilteritinib resistance in FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 1:50 6 years ago 488 Далее Скачать
All about Gilteritinib in 49 seconds #AML #leukemia #cancer #AML HealthTree University for Blood Cancers 0:49 1 year ago 662 Далее Скачать
Improving outcomes for FLT3-mutated R/R AML VJHemOnc – Video Journal of Hematology & HemOnc 2:26 3 years ago 83 Далее Скачать
